Loading...
•
Sep 30, 2023
NRC Q3 2023 Earnings Report
Announced results for the third quarter 2023.
Key Takeaways
NRC Health's third quarter 2023 saw increased new sales compared to the third quarter of 2022, driven by growth in the Human Understanding Program, which was adopted by 91 healthcare organizations. The company is focused on controlling costs and has achieved sequential quarterly operating margin improvement. NRC remains well-positioned to execute capital allocation alternatives, including innovation, growth investments, shareholder dividends, and share repurchases.
New sales increased compared to Q3 2022, driven by the Human Understanding Program.
91 healthcare organizations adopted the Human Understanding Program as of September 30, 2023.
Sequential quarterly operating margin improvement was realized in the last two quarters.
NRC remains well-positioned to execute capital allocation alternatives.
Forward Guidance
NRC Health is focused on controlling costs in an inflationary environment and returning to historical operating margins. The company is well-positioned to execute capital allocation alternatives, including funding innovation and growth investments, shareholder dividends and share repurchases.
Positive Outlook
- Focus on controlling costs in an inflationary environment.
- Sequential quarterly operating margin improvement in the last two quarters.
- Emphasis on returning to historical operating margins.
- Well-positioned to execute the entire range of capital allocation alternatives.
- Funding innovation and growth investments.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...